title: Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies.
abstract: Lung cancer is currently the leading cause of cancer death in Western nations. Non-small cell lung cancer (NSCLC) represents 80% of all lung cancers, and adenocarcinoma is the predominant histological type. Despite the intensive research carried out on this field and therapeutic advances, the overall prognosis of these patients remains unsatisfactory, with a 5-year overall survival rate of less than 15%. Nowadays, pharmacogenetics and pharmacogenomics represent the key to successful treatment. Recent studies suggest the existence of two distinct molecular pathways in the carcinogenesis of lung adenocarcinoma: one associated with smoking and activation of the K-Ras oncogene and the other not associated with smoking and activation of the epidermal growth factor receptor (EGFR). The K-ras mutation is mainly responsible for primary resistance to new molecules which inhibit tyrosine kinase EGFR (erlotinib and gefitinib) and most of the EGFR mutations are responsible for increased tumor sensitivity to these drugs. This article aims to conduct a systematic review of the literature regarding the molecular pathways involving the EGFR, K-Ras and EGFR targeted therapies in NSCLC tumor behavior.
authors.affiliation: Ramon Andrade de Mello, Dânia Sofia Marques, Department of Medical Oncology, Portuguese Oncology Institute, Porto 4200-072, Portugal.
authors.forename: Ramon Andrade
authors.initials: RA
authors.lastname: de Mello
authors.forename: Dânia Sofia
authors.initials: DS
authors.lastname: Marques
authors.forename: Rui
authors.initials: R
authors.lastname: Medeiros
authors.forename: António Mf
authors.initials: AM
authors.lastname: Araújo
references.citation: Science. 1997 Jul 18;277(5324):333-8
references.pmid: 9219684
references.citation: N Engl J Med. 2010 Jun 24;362(25):2380-8
references.pmid: 20573926
references.citation: Oncologist. 2007 Feb;12(2):201-10
references.pmid: 17296816
references.citation: Curr Probl Cancer. 2009 Mar-Apr;33(2):73-111
references.pmid: 19409299
references.citation: Future Oncol. 2010 Feb;6(2):239-47
references.pmid: 20146583
references.citation: Nat Rev Clin Oncol. 2009 Jun;6(6):327-38
references.pmid: 19483739
references.citation: J Clin Oncol. 2011 Aug 20;29(24):3307-15
references.pmid: 21768463
references.citation: N Engl J Med. 2009 Sep 3;361(10):947-57
references.pmid: 19692680
references.citation: Clin Cancer Res. 2010 Jan 1;16(1):279-90
references.pmid: 20028752
references.citation: N Engl J Med. 2005 Jul 14;353(2):123-32
references.pmid: 16014882
references.citation: An Acad Bras Cienc. 2007 Dec;79(4):593-616
references.pmid: 18066431
references.citation: J Cell Sci. 2004 Jun 15;117(Pt 14):2879-86
references.pmid: 15197243
references.citation: J Clin Oncol. 2008 Jan 1;26(1):54-9
references.pmid: 18165640
references.citation: N Engl J Med. 2008 Dec 25;359(26):2814-23
references.pmid: 19109576
references.citation: FASEB J. 2005 Feb;19(2):161-9
references.pmid: 15677339
references.citation: Clin Cancer Res. 2005 Jun 1;11(11):3974-86
references.pmid: 15930332
references.citation: Mol Cancer Res. 2009 Sep;7(9):1466-76
references.pmid: 19737969
references.citation: Br J Cancer. 2005 Jan 17;92(1):131-9
references.pmid: 15597105
references.citation: J Clin Oncol. 2008 Sep 10;26(26):4268-75
references.pmid: 18626007
references.citation: JAMA. 2003 Oct 22;290(16):2149-58
references.pmid: 14570950
references.citation: Clin Cancer Res. 2010 May 1;16(9):2677-87
references.pmid: 20406832
references.citation: Science. 1990 Feb 23;247(4945):939-45
references.pmid: 2406906
references.citation: Carcinogenesis. 2010 Jun;31(6):1080-6
references.pmid: 20400478
references.citation: J Clin Oncol. 2005 Sep 1;23(25):5900-9
references.pmid: 16043828
references.citation: Chest. 2002 Sep;122(3):1037-57
references.pmid: 12226051
references.citation: Mol Cell Biol. 2004 Jul;24(14):6311-23
references.pmid: 15226433
references.citation: Eur J Clin Invest. 1990 Jun;20(3):225-35
references.pmid: 2114981
references.citation: Ann Oncol. 2010 Feb;21(2):217-222
references.pmid: 20110292
references.citation: J Clin Oncol. 2009 Mar 20;27(9):1394-400
references.pmid: 19224850
references.citation: N Engl J Med. 2002 Jan 10;346(2):92-8
references.pmid: 11784875
references.citation: Recent Pat Anticancer Drug Discov. 2012 Jan;7(1):118-31
references.pmid: 21854359
references.citation: Proc Am Thorac Soc. 2009 Apr 15;6(2):218-23
references.pmid: 19349491
references.citation: J Thorac Oncol. 2008 Oct;3(10):1127-32
references.pmid: 18827608
references.citation: J Clin Oncol. 2003 Jun 15;21(12):2237-46
references.pmid: 12748244
references.citation: J Clin Oncol. 2009 Sep 10;27(26):4247-53
references.pmid: 19667264
references.citation: Trends Pharmacol Sci. 2003 Feb;24(2):71-6
references.pmid: 12559770
references.citation: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references.pmid: 21296855
references.citation: Rev Port Pneumol. 2009 Jan-Feb;15(1):67-76
references.pmid: 19145388
references.citation: Anticancer Agents Med Chem. 2010 Mar;10(3):236-49
references.pmid: 20406193
references.citation: J Clin Oncol. 2005 Oct 1;23(28):6829-37
references.pmid: 15998907
references.citation: J Cell Physiol. 2002 Aug;192(2):125-30
references.pmid: 12115718
references.citation: Annu Rev Pathol. 2006;1:331-48
references.pmid: 18039118
references.citation: N Engl J Med. 2011 Feb 24;364(8):777-8
references.pmid: 21345111
references.citation: J Clin Oncol. 2011 Nov 1;29(31):4113-20
references.pmid: 21969500
references.citation: J Clin Oncol. 2009 Jan 10;27(2):264-70
references.pmid: 19047285
references.citation: Lancet Oncol. 2011 Aug;12(8):735-42
references.pmid: 21783417
references.citation: Lancet Oncol. 2010 Feb;11(2):121-8
references.pmid: 20022809
references.citation: Clin Lung Cancer. 2006 Jul;8(1):30-8
references.pmid: 16870043
references.citation: Trends Mol Med. 2010 Jan;16(1):37-45
references.pmid: 20031486
references.citation: J Thorac Oncol. 2008 Oct;3(10):1133-6
references.pmid: 18827609
references.citation: Curr Opin Investig Drugs. 2010 Dec;11(12):1477-90
references.pmid: 21154129
references.citation: N Engl J Med. 2006 Sep 7;355(10):983-91
references.pmid: 16957145
references.citation: N Engl J Med. 2010 Oct 28;363(18):1734-9
references.pmid: 20979473
references.citation: J Thorac Oncol. 2008 May;3(5):457-66
references.pmid: 18448996
references.citation: J Clin Oncol. 2005 Sep 1;23(25):5892-9
references.pmid: 16043829
references.citation: J Clin Oncol. 2010 Nov 1;28(31):4769-77
references.pmid: 20921461
references.citation: J Clin Oncol. 2007 Sep 10;25(26):4033-42
references.pmid: 17827451
references.citation: Int J Oncol. 2000 Mar;16(3):501-11
references.pmid: 10675482
references.citation: Clin Chest Med. 2002 Mar;23(1):83-101
references.pmid: 11901922
references.citation: N Engl J Med. 2005 Jul 14;353(2):172-87
references.pmid: 16014887
references.citation: Cell Mol Life Sci. 2007 Oct;64(19-20):2575-89
references.pmid: 17628742
references.citation: Ann Oncol. 2005;16 Suppl 1:i28-9
references.pmid: 15888743
references.citation: J Clin Oncol. 2005 May 10;23(14):3175-85
references.pmid: 15886304
references.citation: J Clin Oncol. 2011 May 20;29(15):e443-5
references.pmid: 21422405
references.citation: J Clin Oncol. 2002 Jun 15;20(12):2881-94
references.pmid: 12065566
references.citation: J Thorac Oncol. 2007 Jun;2 Suppl 2:S68-76
references.pmid: 17589302
references.citation: Bull Cancer. 2006 Aug;93(8):E101-8
references.pmid: 16935774
references.citation: Lancet. 2005 Oct 29-Nov 4;366(9496):1527-37
references.pmid: 16257339
references.citation: J Clin Oncol. 2008 Mar 20;26(9):1472-8
references.pmid: 18349398
references.citation: J Clin Oncol. 2008 Jul 20;26(21):3543-51
references.pmid: 18506025
references.citation: Clin Lung Cancer. 2007 Feb;8 Suppl 2:S52-60
references.pmid: 17382025
references.citation: N Engl J Med. 2011 Feb 24;364(8):776-7; author reply 778
references.pmid: 21345113
references.citation: CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
references.pmid: 18287387
references.citation: J Clin Oncol. 2011 May 20;29(15):2121-7
references.pmid: 21482992
references.citation: Cancer Control. 2001 Jul-Aug;8(4):326-36
references.pmid: 11483886
references.citation: J Clin Oncol. 2006 Jan 1;24(1):190-205
references.pmid: 16326753
references.citation: Clin Cancer Res. 2010 Jun 1;16(11):3078-87
references.pmid: 20395213
references.citation: J Clin Oncol. 2002 Sep 15;20(18):3906-27
references.pmid: 12228212
references.citation: Lancet Oncol. 2010 Jun;11(6):521-9
references.pmid: 20493771
references.citation: J Thorac Oncol. 2011 Apr;6(4):774-80
references.pmid: 21336183
references.citation: J Clin Oncol. 2004 Oct 15;22(20):4157-64
references.pmid: 15483026
references.citation: J Clin Oncol. 2008 Apr 1;26(10):1742-51
references.pmid: 18375904
references.citation: Cancer Res. 2004 Dec 15;64(24):8919-23
references.pmid: 15604253
references.citation: Int J Cancer. 2007 Mar 15;120(6):1239-47
references.pmid: 17192902
references.citation: J Clin Oncol. 2010 Jan 10;28(2):193-201
references.pmid: 19949019
references.citation: J Clin Oncol. 2005 Oct 1;23(28):6838-45
references.pmid: 15998906
references.citation: Cancer Res. 2010 Mar 15;70(6):2171-9
references.pmid: 20215520
references.citation: Mol Cancer. 2010 Jul 13;9:188
references.pmid: 20624322
references.citation: N Engl J Med. 2008 Sep 25;359(13):1367-80
references.pmid: 18815398
references.citation: J Clin Oncol. 2004 Aug 15;22(16):3238-47
references.pmid: 15310767
references.citation: N Engl J Med. 2004 May 20;350(21):2129-39
references.pmid: 15118073
references.citation: Am J Clin Pathol. 2010 Jun;133(6):922-34
references.pmid: 20472851
references.citation: J Natl Cancer Inst. 2001 Jul 18;93(14):1062-74
references.pmid: 11459867
references.citation: Oncologist. 2007 Feb;12(2):211-20
references.pmid: 17296817
references.citation: Cancer Res. 1996 May 1;56(9):2224-8
references.pmid: 8616876
references.citation: N Engl J Med. 2010 Oct 28;363(18):1693-703
references.pmid: 20979469
references.citation: J Clin Oncol. 2004 May 1;22(9):1589-97
references.pmid: 15117980
references.citation: Biochem J. 1996 Sep 15;318 ( Pt 3):729-47
references.pmid: 8836113